Granulomatous mycosis fungoides is a rare subtype of T-cell cutaneous lymphoma. Due
to its clinical heterogenicity the diagnosis is delayed and based on
histopathological and immuno-histochemical findings, sometimes requiring gene
rearrangement studies for confirmation. We report the case of a patient who was
submitted to several biopsies before diagnostic conclusion.
We present a case of bullosis diabeticorum. It is a rare disorder, probably
underdiagnosed, associated with long-term diabetes mellitus. Its etiology remains
unclear. It is characterized by tense blisters, with serous content, recurrent and
spontaneous on normal skin especially in the acral regions. Displays self-limiting
course. No specific laboratory tests for diagnosis of this bullous disease exist.
Clinical and conservative management to prevent secondary infection reduces morbidity
in diabetic patients.
Mastocytosis is a rare disease characterized by proliferation and accumulation of
mast cells in various organs. The maculopapular cutaneus mastocytosis is divided into
three subtypes: papular/plaque variant, urticaria pigmentosa and eruptive macular
telangiectasia perstans. Dermoscopic may help to better characterize the different
forms of cutaneus mastocytosis. We report a 55 year-old female with urticaria
pigmentosa and its dermoscopy.
Telangiectasia macularis eruptiva perstans is a rare form of cutaneous mastocytosis,
characterized by the presence of erythematous or yellowish-brown macules with
telangiectasias, preferably located on the trunk and upper limbs. We have described a
case of telangiectasia macularis eruptiva perstans focusing on the dermoscopic
characteristics of this disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.